Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 32, 2015 - Issue 10
151
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapy

, , , , , , , , , , , , , , & show all
Pages 1359-1366 | Received 13 Jul 2015, Accepted 09 Sep 2015, Published online: 05 Nov 2015

References

  • Akslen LA, Sothern RB. (1998). Seasonal variations in the presentation and growth of thyroid cancer. Br J Cancer 77:1174–9
  • Borisenkov MF. (2011). Latitude of residence and position in time zone are predictors of cancer incidence, cancer mortality, and life expectancy at birth. Chronobiol Int. 28:155–62
  • Costa IC, Carvalho HN, Fernandes L. (2013). Aging, circadian rhythms and depressive disorders: A review. Am J Neurodegener Dis. 2:228–46
  • Eisenhauer EA, Therasse P, Bogaerts J, et al. (2009). New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–47
  • Galea MH, Blamey RW. (1991). Season of initial detection in breast cancer. Br J Cancer. 63:157
  • Gamelin EC, Danquechin-Dorval EM, Dumesnil YF, et al. (1996). Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU. Cancer. 77:441–51
  • Garland CF, Garland FC. (2006). Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 35:217–20
  • Garufi C, Lévi F, Aschelter AM, et al. (1997). A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer. Eur J Cancer. 33:1566–71
  • Halberg F. (1969). Chronobiology. Annu Rev Physiol. 31:675–725
  • Heinemann V, von Weikersthal LF, Decker T, et al. (2014). FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastaticcolorectal cancer (FIRE-3): A randomised, open-label, phase 3 trial. Lancet Oncol. 15:1065–75
  • Joensuu H, Toikkanen S. (1991). Association between the month of diagnosis and prognosis in breast carcinoma. Br J Cancer. 64:753–6
  • Mason BH, Holdaway IM, Stewart AW, et al. (1990).Season of initial discovery of tumor as an independent variable predicting survival in breast cancer. Br J Cancer. 61:137–41
  • Miller AB, Hoogstroten B, Staquet M, et al. (1981). Reporting results of cancer treatment. Cancer. 47:207–14
  • Moan J, Lagunova Z, Bruland Ø, Juzeniene A. (2010). Seasonal variations of cancer incidence and prognosis. Dermatoendocrinol. 2:55–7
  • Ng K, Sargent DJ, Goldberg RM, Meyerhardt JA, et al. (2011). Vitamin D status in patients with stage IV colorectal cancer: Findings from intergroup trial N9741. J Clin Oncol. 29:1599–606
  • Pugliese P, Garufi C, Perrone M, et al. (2002). Quality of life and chronotherapy. Chronobiol Int. 19:299–312
  • Robsahm TE, Tretli S, Dahlback A, Moan J. (2004). Vitamin D3 from sunlight may improve the prognosis of breast, colon and prostate cancer (Norway). Cancer Causes Control. 15:149–58
  • Sankila R, Joensuu H, Pukkala E, Toikkanen S. (1993). Does the month of diagnosis affect survival of cancer patients? Br J Cancer. 67:838–41
  • Smaaland R, Lote K, Sothern RB, Laerum OD. (1993). DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling. Cancer Res. 53:3129–38
  • Steindal AH, Porojnicu AC, Moan J. (2007). Is the seasonal variation in cancer prognosis caused by sun-induced folate degradation? Med Hypotheses. 69:182–5
  • Tournigand C, André T, Achille E, et al. (2004). FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol. 22:229–37
  • Zgaga L, Theodoratou E, Farrington SM, et al. (2014). Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer. J Clin Oncol. 32:2430–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.